你即將離開本站

並前往https://www.boehringerone.com/my/inflammation/nintedanib/efficacy/listen-our-experts-share-their-insights-why-inbuild-important-study-patients-pf-ild

INBUILD® Trial Introduction | boehringerone.com

OFEV ® (nintedanib) is approved for the treatment of progressive fibrosing interstitial lung disease (PF-ILD). systemic sclerosis-associated ...

確定！ 回上一頁

查詢 「INBUILD trial」的人也找了：

  1. INBUILD trial
    2.
  2. SENSCIS trial
    3.
  3. Nintedanib clinical trial
    4.
  4. pf-ild definition
    5.
  5. Pirfenidone
    6.
  6. TOMORROW trial
    7.
  7. RELIEF pirfenidone
    8.
  8. Progressive fibrosing interstitial lung disease
    9.